~9 spots leftby Aug 2026

Behavioral Therapy for Early Psychosis

Recruiting in Palo Alto (17 mi)
SR
Overseen byStephanie Rolin, MD, MPH
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Columbia University
Disqualifiers: Unable to consent, Not fluent English
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This trial is testing a program that helps people with early psychosis learn new ways to manage their emotions and actions to reduce violent behavior.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Adapted Behavioral Intervention for early psychosis?

Research shows that cognitive-behavioral therapy for psychosis (CBTp) can be effective for persistent symptoms, especially when introduced during a stable phase of early psychosis. Additionally, cognitive adaptation training (CAT), a similar behavioral intervention, has shown improvements in functioning and symptoms in people with schizophrenia, suggesting potential benefits for early psychosis as well.12345

Is behavioral therapy for early psychosis safe for humans?

Research on cognitive-behavioral therapy (CBT) for psychosis, which is similar to behavioral therapy, suggests it is generally safe for humans. An Internet-based CBT program for psychosis was found to be feasible and safe compared to usual care.12678

How is the Adapted Behavioral Intervention treatment for early psychosis different from other treatments?

Adapted Behavioral Intervention for early psychosis is unique because it focuses on behavioral therapy tailored to the individual's needs, potentially during a stable phase rather than an acute phase, which may improve long-term outcomes. This approach contrasts with traditional treatments that often involve medication or are introduced during acute episodes.2391011

Research Team

SR

Stephanie Rolin, MD, MPH

Principal Investigator

Columbia University

Eligibility Criteria

This trial is for young adults aged 16 to 30 who are receiving treatment for early psychosis at OnTrackNY clinics and can participate in research interviews. They must have a diagnosis within the schizophrenia spectrum, excluding affective psychoses, and be fluent in English.

Inclusion Criteria

I am aged 16-30 and have been diagnosed with a type of nonaffective psychosis.
I am willing to do interviews after each study visit.
I am receiving treatment for my first episode of psychosis at an OnTrackNY clinic.

Exclusion Criteria

I am not fluent in English.
I am unable to understand and give consent for treatment.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 12-week behavioral intervention to reduce violent behavior

12 weeks
Weekly sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Adapted Behavioral Intervention (Behavioral Intervention)
Trial OverviewThe study tests an adapted behavioral intervention designed to reduce violent behavior in individuals with early-stage nonaffective psychotic disorders such as schizophrenia.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: behavioral interventionExperimental Treatment1 Intervention
This will involve conducting a 12-week open pilot trial (up to n=16 dyads of EIS clinicians-EIS participants) to test the feasibility and acceptability of the adapted Psychological Interventions for Coping with Anger and Schizophrenia: a study of outcomes (PICASSO) intervention in the OnTrackNY setting.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+
Dr. Katrina Armstrong profile image

Dr. Katrina Armstrong

Columbia University

Chief Executive Officer

MD from Johns Hopkins University, MS in Epidemiology from Harvard School of Public Health

Dr. Katrina Armstrong profile image

Dr. Katrina Armstrong

Columbia University

Chief Medical Officer

MD from Harvard Medical School

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Dr. Joshua A. Gordon

National Institute of Mental Health (NIMH)

Chief Executive Officer since 2016

MD, PhD

Dr. Shelli Avenevoli profile image

Dr. Shelli Avenevoli

National Institute of Mental Health (NIMH)

Chief Medical Officer

PhD

Findings from Research

A modified version of Cognitive Adaptation Training (CAT) was tested with 23 participants, showing significant improvements in adaptive functioning, psychiatric symptoms, and goal attainment after 4 months of intervention and 5 months of case management support.
The study suggests that a shorter, supported version of CAT can maintain its positive effects on individuals with schizophrenia, indicating that ongoing case management can help sustain treatment benefits.
Testing a modification of cognitive adaptation training: streamlining the model for broader implementation.Kidd, SA., Herman, Y., Barbic, S., et al.[2018]
A 25-session cognitive-behavioral therapy program for early psychosis showed significant improvements in psychotic symptoms among 20 patients, with effects maintained at a 6-month follow-up.
The program had a high acceptance rate of 75% and an 84% compliance rate, indicating that the treatment dosage and structure were effective in engaging participants, including adolescents.
[Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting].Marois, MJ., Gingras, N., Provencher, MD., et al.[2018]
Users in both Brazil and Chile found the task-shifting approach of the CTI-TS program to be beneficial, appreciating the personalized support it provided, but expressed a desire for longer intervention durations to maintain benefits.
The study highlighted significant contextual differences, such as stigma and community violence, that affected engagement with the program, suggesting that adaptations to interventions must consider local social factors for effective implementation.
Implementation of a pilot community-based psychosocial intervention for patients with psychoses in Chile and Brazil: a comparative analysis of users' perspectives.Dev, S., Kankan, T., Blasco, D., et al.[2023]

References

Testing a modification of cognitive adaptation training: streamlining the model for broader implementation. [2018]
[Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting]. [2018]
Implementation of a pilot community-based psychosocial intervention for patients with psychoses in Chile and Brazil: a comparative analysis of users' perspectives. [2023]
Implementing Patient-Reported Outcomes to Improve the Quality of Care for Weight of Patients with Schizophrenia. [2020]
The Effect of Intensive Implementation Support on Fidelity for Four Evidence-Based Psychosis Treatments: A Cluster Randomized Trial. [2022]
Factor structure of therapist fidelity to individual resiliency training in the Recovery After an Initial Schizophrenia Episode Early Treatment Program. [2019]
Internet-based self-help for psychosis: Findings from a randomized controlled trial. [2021]
A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis. [2021]
Psychosocial and psychological interventions in early psychosis: essential elements for recovery. [2014]
Domiciliary intervention in psychosis: a systematic review. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Cognitive-behavioral therapy for individuals at high risk of developing psychosis. [2018]